Does TOCILIZUMAB Cause Diffuse alveolar damage? 25 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Diffuse alveolar damage have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.
25
Reports of Diffuse alveolar damage with TOCILIZUMAB
0.0%
of all TOCILIZUMAB reports
11
Deaths
11
Hospitalizations
How Dangerous Is Diffuse alveolar damage From TOCILIZUMAB?
Of the 25 reports, 11 (44.0%) resulted in death, 11 (44.0%) required hospitalization, and 10 (40.0%) were considered life-threatening.
Is Diffuse alveolar damage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Diffuse alveolar damage?
METHYLPREDNISOLONE (135)
CYCLOPHOSPHAMIDE (125)
PREDNISONE (122)
METHOTREXATE (112)
DEXAMETHASONE (84)
VINCRISTINE (78)
CYTARABINE (76)
DAUNORUBICIN (75)
ETOPOSIDE (73)
LEUCOVORIN (73)
Which TOCILIZUMAB Alternatives Have Lower Diffuse alveolar damage Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE